z-logo
open-access-imgOpen Access
Anti-Tumor Activities of the Antlered Form ofGanoderma lucidumin Allogeneic and Syngeneic Tumor-Bearing Mice
Author(s) -
Yuji aka,
Hiroshi Shibata,
Masaaki Nakai,
Hiroshi Kurihara,
Hiroko Ishibashi,
Yoshinobu Kiso,
Takaharu Tanaka,
Hideyo Yamaguchi,
Shigeru Abe
Publication year - 2006
Publication title -
bioscience biotechnology and biochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.509
H-Index - 116
eISSN - 1347-6947
pISSN - 0916-8451
DOI - 10.1271/bbb.50509
Subject(s) - ganoderma lucidum , interferon , medicine , cancer research , cd8 , pharmacology , chemistry , immunology , immune system , traditional medicine
We investigated the anti-tumor effects of a dry powder preparation of the antlered form of Ganoderma lucidum (G. lucidum AF, rokkaku-reishi in Japanese), a variant type of G. lucidum, not only in allogeneic Sarcoma 180-bearing ddY mice, but also in syngeneic MM 46-bearing C3H/He mice. G. lucidum AF inhibited tumor growth and elongated the life span when orally administered to mice by free-feeding of a 2.5% G. lucidum AF-containing diet. It also showed anti-tumor activity in spite of post-feeding after tumor inoculation. G. lucidum AF significantly countered the depression of splenic CD8+ cells and protected the decrease in interferon-gamma (IFN-gamma) production in regional lymph nodes of MM 46-bearing mice, indicating that the anti-tumor activity of G. lucidum AF might be caused by its immunostimulating action. These results suggest that the ingestion of G. lucidum AF can be useful for the prevention and curing of cancer.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom